Health Catalyst Stock Analysis

HCAT Stock  USD 2.17  0.04  1.81%   
Below is the normalized historical share price chart for Health Catalyst extending back to July 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Health Catalyst stands at 2.17, as last reported on the 28th of January, with the highest price reaching 2.24 and the lowest price hitting 2.17 during the day.
IPO Date
25th of July 2019
200 Day MA
3.2537
50 Day MA
2.4413
Beta
1.696
 
Covid
 
Interest Hikes
Health Catalyst holds a debt-to-equity ratio of 0.529. At this time, Health Catalyst's Cash Flow To Debt Ratio is comparatively stable compared to the past year. Health Catalyst's financial risk is the risk to Health Catalyst stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Health Catalyst's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Health Catalyst's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Health Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Health Catalyst's stakeholders.
For most companies, including Health Catalyst, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Health Catalyst, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Health Catalyst's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
0.4709
Enterprise Value Ebitda
(4.96)
Price Sales
0.4968
Shares Float
59.9 M
Wall Street Target Price
3.875
At this time, Health Catalyst's Total Stockholder Equity is comparatively stable compared to the past year. Common Stock is likely to gain to about 1.9 B in 2026, whereas Liabilities And Stockholders Equity is likely to drop slightly above 583.9 M in 2026. . At this time, Health Catalyst's Price Earnings To Growth Ratio is comparatively stable compared to the past year. Price To Operating Cash Flows Ratio is likely to gain to 27.62 in 2026, whereas Price Book Value Ratio is likely to drop 0.99 in 2026.
Health Catalyst is undervalued with Real Value of 2.87 and Target Price of 3.88. The main objective of Health Catalyst stock analysis is to determine its intrinsic value, which is an estimate of what Health Catalyst is worth, separate from its market price. There are two main types of Health Catalyst's stock analysis: fundamental analysis and technical analysis.
The Health Catalyst stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Health Catalyst is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Health Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Catalyst. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.

Health Stock Analysis Notes

About 80.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Health Catalyst recorded a loss per share of 1.58. The entity had not issued any dividends in recent years. Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah. Health Catalyst operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1200 people. To learn more about Health Catalyst call Daniel Burton at 801 708 6800 or check out https://www.healthcatalyst.com.

Health Catalyst Quarterly Total Revenue

76.32 Million

Health Catalyst Investment Alerts

Health Catalyst generated a negative expected return over the last 90 days
Health Catalyst has high historical volatility and very poor performance
Health Catalyst has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 306.58 M. Net Loss for the year was (69.5 M) with profit before overhead, payroll, taxes, and interest of 150.11 M.
Over 80.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Data Analytics Stocks Q3 Highlights Amplitude

Health Largest EPS Surprises

Earnings surprises can significantly impact Health Catalyst's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-05-07
2025-03-310.030.01-0.0266 
2024-05-09
2024-03-310.030.050.0266 
2024-02-22
2023-12-31-0.00020.020.020210100 
View All Earnings Estimates

Health Catalyst Environmental, Social, and Governance (ESG) Scores

Health Catalyst's ESG score is a quantitative measure that evaluates Health Catalyst's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Health Catalyst's operations that may have significant financial implications and affect Health Catalyst's stock price as well as guide investors towards more socially responsible investments.

Health Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Kennedy Capital Management Inc2025-06-30
1.1 M
Connor Clark & Lunn Inv Mgmt Ltd2025-06-30
1.1 M
Jpmorgan Chase & Co2025-06-30
909.4 K
Palogic Value Management Lp2025-06-30
730.1 K
Charles Schwab Investment Management Inc2025-06-30
598.6 K
Northern Trust Corp2025-06-30
527 K
Martin & Co Inc2025-06-30
509.2 K
Schroder Investment Management Group2025-06-30
468.7 K
Amh Equity Ltd2025-06-30
427.1 K
First Light Asset Management, Llc2025-06-30
12.2 M
Blackrock Inc2025-06-30
5.7 M
Note, although Health Catalyst's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Health Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 157.02 M.

Health Profitablity

The company has Profit Margin (PM) of (0.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.13)(0.12)
Return On Assets(0.07)(0.08)
Return On Equity(0.22)(0.23)

Management Efficiency

Health Catalyst has return on total asset (ROA) of (0.0474) % which means that it has lost $0.0474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3133) %, meaning that it created substantial loss on money invested by shareholders. Health Catalyst's management efficiency ratios could be used to measure how well Health Catalyst manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.13 in 2026. Return On Capital Employed is likely to gain to -0.12 in 2026. At this time, Health Catalyst's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 192.5 M in 2026, whereas Liabilities And Stockholders Equity is likely to drop slightly above 583.9 M in 2026.
Last ReportedProjected for Next Year
Book Value Per Share 5.46  5.73 
Tangible Book Value Per Share 0.29  0.30 
Enterprise Value Over EBITDA(62.42)(59.29)
Price Book Value Ratio 1.05  0.99 
Enterprise Value Multiple(62.42)(59.29)
Price Fair Value 1.05  0.99 
Enterprise Value632.5 M871.1 M
Evaluating the management effectiveness of Health Catalyst allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Health Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(0.10)
Profit Margin
(0.34)
Beta
1.696
Return On Assets
(0.05)
Return On Equity
(0.31)

Technical Drivers

As of the 28th of January, Health Catalyst retains the risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (0.56). Health Catalyst technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Health Catalyst Price Movement Analysis

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Moving Average is predictive technique used to analyze Health Catalyst price data points by creating a series of averages of different subsets of Health Catalyst entire price series.

Health Catalyst Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Health Catalyst insiders, such as employees or executives, is commonly permitted as long as it does not rely on Health Catalyst's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Health Catalyst insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Health Catalyst Outstanding Bonds

Health Catalyst issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Health Catalyst uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Health bonds can be classified according to their maturity, which is the date when Health Catalyst has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Health Catalyst Predictive Daily Indicators

Health Catalyst intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Health Catalyst stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Health Catalyst Forecast Models

Health Catalyst's time-series forecasting models are one of many Health Catalyst's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Health Catalyst's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Health Catalyst Bond Ratings

Health Catalyst financial ratings play a critical role in determining how much Health Catalyst have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Health Catalyst's borrowing costs.
Piotroski F Score
5
HealthyView
Beneish M Score
(3.76)
Unlikely ManipulatorView

Health Catalyst Debt to Cash Allocation

Health Catalyst currently holds 402.26 M in liabilities with Debt to Equity (D/E) ratio of 0.53, which is about average as compared to similar companies. Health Catalyst has a current ratio of 5.05, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Health Catalyst's use of debt, we should always consider it together with its cash and equity.

Health Catalyst Total Assets Over Time

Health Catalyst Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Health Catalyst uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Health Catalyst Debt Ratio

    
  22.0   
It appears most of the Health Catalyst's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Health Catalyst's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Health Catalyst, which in turn will lower the firm's financial flexibility.

Health Catalyst Corporate Bonds Issued

Health Short Long Term Debt Total

Short Long Term Debt Total

485.73 Million

At this time, Health Catalyst's Short and Long Term Debt Total is comparatively stable compared to the past year.

About Health Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Health Catalyst prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Health shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Health Catalyst. By using and applying Health Stock analysis, traders can create a robust methodology for identifying Health entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.20)(0.21)
Operating Profit Margin(0.20)(0.22)
Net Loss(0.20)(0.21)
Gross Profit Margin 0.41  0.38 

Current Health Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Health analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Health analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
3.88Strong Buy13Odds
Health Catalyst current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Health analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Health stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Health Catalyst, talking to its executives and customers, or listening to Health conference calls.
Health Analyst Advice Details

Health Stock Analysis Indicators

Health Catalyst stock analysis indicators help investors evaluate how Health Catalyst stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Health Catalyst shares will generate the highest return on investment. By understating and applying Health Catalyst stock analysis, traders can identify Health Catalyst position entry and exit signals to maximize returns.
Begin Period Cash Flow106.3 M
Total Stockholder Equity365.2 M
Capital Lease Obligations19.9 M
Property Plant And Equipment Net41.5 M
Cash And Short Term Investments392 M
Cash249.6 M
50 Day M A2.4413
Net Interest Income896 K
Total Current Liabilities325.9 M
Forward Price Earnings13.0039
Investments-22.9 M
Interest Expense17.1 M
Stock Based Compensation40.1 M
Long Term Debt151.2 M
Common Stock Shares Outstanding60.2 M
Total Cashflows From Investing Activities-22.9 M
Tax Provision333 K
Accounts Payable11.4 M
Net Debt152.6 M
Other Operating Expenses376.4 M
Non Current Assets Total393.3 M
Liabilities And Stockholders Equity858.9 M
Non Currrent Assets OtherM

Additional Tools for Health Stock Analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.